Med Ed Report briefs

Share this article:
J&J's Cordis Corporation named Dr. Christian Spaulding worldwide VP of medical affairs.  Spaulding is director of the cardiac cath lab at Cochin Hospital and professor of medicine at Rene Descartes University.

The American College of Physicians (ACP) achieved Accreditation with Commendation from the ACCME. The recognition marks the second consecutive time ACP has accomplished the distinction. Its new term of accreditation continues until March 31, 2016.

The head of the National Institute of Mental Health, Dr. Thomas Insel, wrote in JAMA that American psychiatrists need to break away from a “culture of influence” created by their financial dealings with the industry. In Vermont, psychiatrists received more money from drug companies than all other medical specialists, he noted.

Georgetown University Medical Center will co-host “Prescription for Conflict: Should Industry Fund CME?” a conference featuring Murray Kopelow, Dave Davis, Mike Saxton and PharmedOut.org's Adriane Fugh-Berman (pictured), among others. The June 25 conference will take place at the Georgetown University Intercultural Center Auditorium.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?